With over 25 years of central laboratory experience, the network currently supports clinical trials in over 85 countries across all continents. Four wholly owned central laboratory sites in the United States, the Netherlands, Singapore and China operate under global quality standards, SOPs and IT infrastructure, ensuring data is inherently combinable. Complementing the four central laboratory facilities, our fifth CAP-accredited pathology laboratory in the United States serves as an extension of the global laboratory network, further enhancing its specialised testing capabilities.

The global quality system of Eurofins Central Laboratory is designed to encompass the relevant aspects of both international and country-specific quality standards. The quality system of Eurofins Central Laboratory is based on regulatory standards GCLP, GCP, and CLIA, and quality standards CAP, ISO/IEC17025 and ISO15189.